Abstract
The aim of the present study was twofold. First, we studied the differential demographic and clinical features regarding social phobia subtype and axis II comorbidity. Second, we studied the role of social phobia subtype and axis II comorbidity in treatment effectiveness. The sample included 28 patients diagnosed of social phobia (DSM-IV, APA, 1994). We divided the sample attending to social phobia subtype and axis II comorbidity. When we compared the groups, we did not find significant differences in demographic variables. However, we found differences regarding clinical variables: Patients with generalized social phobia were more impaired than patients with circumscribed social phobia; patients with axis II comorbidity were also more impaired than patients without axis II comorbidity. All patients were treated with a group cognitive-behavioral program, adapted from Heimberg, Juster, Hope & Mattia (1995). There were no differences in effectiveness regarding the different sub-samples. However, some of the clinical differences found at the pre-treatment regarding some clinical variables disappeared after the termination of the treatment.
